reckitt benckiser , the company behind nurofen in australians , will square off against the accc ( accc ) in federal court this month over claims that it has mislead customers
the accc will dispute claims made by the company that the nurofen specific pain range is specially designed to target different types of pain
accc chairman rod sims said cracking down on false advertising surrounding medical products was a targetted priority for the watchdog
' the accc takes false or misleading claims about the efficacy of health and medical products very seriously , ' mr rod sims said
' ' the accc takes false or misleading claims about the efficacy of health and medical products very seriously , ' chairman rod sims said
the matter is listed for a case management conference in the federal court of australia in sydney on march 31 .